Home |
Free Dividend Report |
Stock Splits Calendar |
GLYC Historical Stock Prices |
Preferred Stock Newsletter |
GLYC Options Chain |
Stock Message Boards |
GlycoMimetics (GLYC) has the following price history information. Looking back at GLYC historical stock prices for the last five trading days, on April 18, 2024, GLYC opened at $2.29, traded as high as $2.36 and as low as $2.15, and closed at $2.16. Trading volume was a total of 876.00K shares. On April 19, 2024, GLYC opened at $2.17, traded as high as $2.17 and as low as $1.88, and closed at $1.93. Trading volume was a total of 1.17M shares. On April 22, 2024, GLYC opened at $1.94, traded as high as $2.05 and as low as $1.80, and closed at $1.80. Trading volume was a total of 1.48M shares. On April 23, 2024, GLYC opened at $1.80, traded as high as $1.86 and as low as $1.74, and closed at $1.84. Trading volume was a total of 1.23M shares. On April 24, 2024, GLYC opened at $1.99, traded as high as $1.99 and as low as $1.79, and closed at $1.86. Trading volume was a total of 656.90K shares.
GLYC Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into GlycoMimetics shares, starting with a $10,000 purchase of GLYC, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/28/2014 | |
End date: | 04/24/2024 | |
Start price/share: | $13.08 | |
End price/share: | $1.86 | |
Dividends collected/share: | $0.00 | |
Total return: | -85.78% | |
Average Annual Total Return: | -17.73% | |
Starting investment: | $10,000.00 | |
Ending investment: | $1,421.17 | |
Years: | 10.00 |
GLYC Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/18/2024 | $2.29 | $2.36 | $2.15 | $2.16 | 876.00K |
04/19/2024 | $2.17 | $2.17 | $1.88 | $1.93 | 1.17M |
04/22/2024 | $1.94 | $2.05 | $1.80 | $1.80 | 1.48M |
04/23/2024 | $1.80 | $1.86 | $1.74 | $1.84 | 1.23M |
04/24/2024 | $1.99 | $1.99 | $1.79 | $1.86 | 656.90K |
About GlycoMimetics |
GlycoMimetics is a clinical-stage biotechnology company focused on improving the lives of people living with cancer and inflammatory diseases by utilizing the inhibition of carbohydrate interactions that occur on the surface of cells. Co. is developing uproleselan, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia, a hematologic cancer, and potentially other hematologic cancers. Co. has designed an antagonist of E-selectin, GMI-1687, that could be suitable for subcutaneous administration. Co. has also selected a primary galectin drug candidate, GMI-2093, for evaluation in preclinical studies. |
GLYC Historical Closing Prices | |
Date | Close |
04/18/2024 | $2.16 |
04/19/2024 | $1.93 |
04/22/2024 | $1.80 |
04/23/2024 | $1.84 |
04/24/2024 | $1.86 |
Healthcare Historical Prices |
GLYC is categorized under the Healthcare sector; below are some other companies in the same sector:
GMED Historical Stock Prices Also explore: GLYC shares outstanding history
Free GLYC Email Alerts:
|
GLYC Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.